Αlpha Beta (α/β) T cell Depleted Second HCT Is Effective for Impending Secondary Graft Failure after Reduced Intensity and Nonmyeloablative MSD HCT in Sickle Cell Disease | Synapse
March 3, 2026
Αlpha Beta (α/β) T cell Depleted Second HCT Is Effective for Impending Secondary Graft Failure after Reduced Intensity and Nonmyeloablative MSD HCT in Sickle Cell Disease
Key Points
Second hematopoietic cell transplantation effectively addresses impending graft failure in sickle cell disease.
Primary outcome showed successful prevention of graft failure using alpha beta T cell depletion in patients.
Analysis of hematopoietic cell transplantation records highlights reduced intensity and nonmyeloablative methods.
Supports the potential of this treatment approach, but further studies are necessary to validate findings.